Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

BACKGROUND: Type I interferons (IFN-I) contribute to a broad range of rheumatic and musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of IFN-I pathway activation may have clinical value. Although several IFN-I pathway assays have been proposed, the exact clinical app...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Carrio, Javier, Burska, Agata, Conaghan, P G, Dik, Willem A, Biesen, Robert, Eloranta, Maija-Leena, Cavalli, Giulio, Visser, Marianne, Boumpas, Dimitrios T, Bertsias, George, Wahren-Herlenius, Marie, Rehwinkel, Jan, Frémond, Marie-Louise, Crow, Mary K, Ronnblom, Lars, Vital, Ed, Versnel, Marjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008483/
https://www.ncbi.nlm.nih.gov/pubmed/36882218
http://dx.doi.org/10.1136/rmdopen-2022-002864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008483/
https://www.ncbi.nlm.nih.gov/pubmed/36882218
http://dx.doi.org/10.1136/rmdopen-2022-002864

Ejemplares similares